BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary EndpointSubjects with Confirmed SAD who Received BNC210 Exhibited Trends Toward.
Poorer sleep quality is prevalent among patients with JME who are pharmacoresistant, highlighting the need for special care to prevent seizure worsening.
Poorer sleep quality is prevalent among patients with JME who are pharmacoresistant, highlighting the need for special care to prevent seizure worsening.
Getting medical physicists involved with patient care by having them explain what will be involved helps to reduce patient anxiety and increases overall patient satisfaction, suggest results of a new trial.